Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors

Jolien De Neve, Thomas M. A. Barlow, Dirk Tourwe, Frederic Bihel, Frederic Simonin, Steven Ballet

Research output: Other contribution

Abstract

One of the main challenges in contemporary medicinal chemistry is the development of safer analgesics, used in the treatment of pain. Currently, moderate to severe pain is still treated with the “gold standard” opioids whose long-term often leads to severe side effects. With the discovery of biased agonism, the importance of this area of pharmacology has grown exponentially over the past decade. Of these side effects, tolerance, opioid misuse, physical dependence and substance use disorder (SUD) stand out, since these have led to many deaths over the past decades in both USA and Europe. New therapeutic molecules that induce a biased response at the opioid receptors (MOR, DOR, KOR and NOP receptor) are able to circumvent these side effects and, consequently, serve as more advantageous therapies with great promise. The concept of biased signaling extends far beyond the already sizeable field of GPCR pharmacology and covering everything would be vastly outside the scope of this review which consequently covers the biased ligands acting at the opioid family of receptors. The limitation of quantifying bias, however, makes this a controversial subject, where it is dependent on the reference ligand, the equation or the assay used for the quantification. Hence, the major issue in the field of biased ligands remains the translation of thein vitroprofiles of biased signaling, with corresponding bias factors toin vivoprofiles showing the presence or the lack of specific side effects. This review comprises a comprehensive overview of biased ligands in addition to their bias factors at individual members of the opioid family of receptors, as well as bifunctional ligands.

Original languageEnglish
Number of pages43
Edition6
Volume12
DOIs
Publication statusPublished - Jun 2021

Publication series

NameRSC Medicinal Chemistry
ISSN (Print)2632-8682

Cite this